ES2072848T3 - Nuevo procedimiento de preparacion de finasterida. - Google Patents

Nuevo procedimiento de preparacion de finasterida.

Info

Publication number
ES2072848T3
ES2072848T3 ES95200270T ES95200270T ES2072848T3 ES 2072848 T3 ES2072848 T3 ES 2072848T3 ES 95200270 T ES95200270 T ES 95200270T ES 95200270 T ES95200270 T ES 95200270T ES 2072848 T3 ES2072848 T3 ES 2072848T3
Authority
ES
Spain
Prior art keywords
finasteride
magnesium halide
discovered
preparation
new procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95200270T
Other languages
English (en)
Other versions
ES2072848T1 (es
Inventor
Ulf H Dolling
James A Mccauley
Richard J Varsolona
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26681536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2072848(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES2072848T1 publication Critical patent/ES2072848T1/es
Application granted granted Critical
Publication of ES2072848T3 publication Critical patent/ES2072848T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N5/00—Details of television systems
    • H04N5/74—Projection arrangements for image reproduction, e.g. using eidophor
    • H04N5/7416—Projection arrangements for image reproduction, e.g. using eidophor involving the use of a spatial light modulator, e.g. a light valve, controlled by a video signal
    • H04N5/7458—Projection arrangements for image reproduction, e.g. using eidophor involving the use of a spatial light modulator, e.g. a light valve, controlled by a video signal the modulator being an array of deformable mirrors, e.g. digital micromirror device [DMD]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Multimedia (AREA)
  • Signal Processing (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Confectionery (AREA)
  • Dental Preparations (AREA)
  • Seasonings (AREA)

Abstract

SE DESCUBRE UN NUEVO PROCESO PARA PRODUCIR FINASTERURO QUE IMPLICA HACER REACCIONAR LA SAL DE MAGNESIO HALURO DE 17BETA-CARBOALCOXI-4AZA-5ALFA-ANDROST-1-EN-3-ONA CON HALURO DE MAGNESIO T-BUTILAMINO, PRESENTE EN AL MENOS UNA PROPORCION MOLAR DE 2:1 EN EL ESTER, FORMADO A PARTIR DE T-BUTIL AMINO Y UN HALURO DE MAGNESIO ALIFATICO/ARIL A TEMPERATURA AMBIENTE EN UN SOLVENTE ORGANICO INERTE BAJO UNA ATMOSFERA INERTE SEGUIDO POR EL CALENTAMIENTO Y RECUPERACION DEL PRODUCTO FINASTERURO. TAMBIEN SE DESCUBREN DOS FORMAS I Y II POLIMORFICAS CRISTALINAS DE FINASTERURO Y METODOS PARA SU PRODUCCION.
ES95200270T 1992-11-19 1993-11-12 Nuevo procedimiento de preparacion de finasterida. Expired - Lifetime ES2072848T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97853592A 1992-11-19 1992-11-19
US08/010,734 US5468860A (en) 1992-11-19 1993-01-29 New finasteride processes

Publications (2)

Publication Number Publication Date
ES2072848T1 ES2072848T1 (es) 1995-08-01
ES2072848T3 true ES2072848T3 (es) 1999-05-01

Family

ID=26681536

Family Applications (2)

Application Number Title Priority Date Filing Date
ES93203163T Expired - Lifetime ES2052476T5 (es) 1992-11-19 1993-11-12 Un procedimiento para la produccion de finasterida.
ES95200270T Expired - Lifetime ES2072848T3 (es) 1992-11-19 1993-11-12 Nuevo procedimiento de preparacion de finasterida.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES93203163T Expired - Lifetime ES2052476T5 (es) 1992-11-19 1993-11-12 Un procedimiento para la produccion de finasterida.

Country Status (32)

Country Link
US (3) US5468860A (es)
EP (3) EP0655458B1 (es)
JP (2) JPH07110875B2 (es)
CN (1) CN1058018C (es)
AT (2) ATE177112T1 (es)
AU (1) AU658774B2 (es)
BG (2) BG62362B1 (es)
CA (1) CA2103107C (es)
CY (1) CY2135B1 (es)
CZ (3) CZ287842B6 (es)
DE (4) DE655458T1 (es)
DK (2) DK0599376T4 (es)
DZ (1) DZ1733A1 (es)
ES (2) ES2052476T5 (es)
FI (4) FI107450B (es)
GR (4) GR940300045T1 (es)
HR (2) HRP931410B1 (es)
HU (2) HU216195B (es)
IL (1) IL107574A (es)
IS (2) IS1692B (es)
LV (2) LV12212B (es)
MX (1) MX9307222A (es)
MY (2) MY110410A (es)
NO (3) NO305912B1 (es)
PH (1) PH31120A (es)
RO (2) RO115164B1 (es)
RU (1) RU2120445C1 (es)
SI (1) SI9300603B (es)
SK (2) SK286488B6 (es)
TW (1) TW257766B (es)
UA (1) UA41341C2 (es)
WO (1) WO1994011387A2 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
IT1270660B (it) * 1994-10-13 1997-05-07 Poli Ind Chimica Spa Procedimento microbiologico per la preparazione di 3-oxo-4-azasteroidi-17beta-carbossi sostituiti e uso dei prodotti come inibitori dell'enzima 5alfa-riduttasi
US5670643A (en) * 1995-03-16 1997-09-23 Glaxo Wellcome Inc. Method for preparing finasteride
US5585383A (en) * 1995-05-03 1996-12-17 Merck & Co., Inc. Process for crystallizing a 4-azasteroid 5alpha-reductase inhibitor
AU707324B2 (en) * 1995-09-15 1999-07-08 Merck & Co., Inc. 4-azasteroids for treatment of hyperandrogenic conditions
GB2338234B (en) * 1998-06-10 2000-05-03 Torcan Chemical Ltd Preparation of finasteride
ES2153789B1 (es) * 1999-07-05 2001-10-16 Raga Consultores S L Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides
EA200200524A1 (ru) * 1999-11-01 2002-10-31 Торкан Кемикал Лтд. Получение полиморфных форм i и ii финастерида путем образования комплексов с солями металлов группы i или ii
WO2002020553A1 (en) * 2000-09-07 2002-03-14 Dr. Reddy's Laboratories Ltd. NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT
AU2001269911B2 (en) * 2000-09-07 2006-09-21 Dr. Reddy's Laboratories Ltd. Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it
SK2732003A3 (en) * 2000-09-07 2004-01-08 Reddys Lab Ltd Dr Novel polymorphic form of 17-beta-(N-ter.butyl carbamoyl)-4-aza- 5-alpha-androst-1-en-3-one and a process for preparing it
KR100415858B1 (ko) * 2001-09-22 2004-01-24 한미약품 주식회사 17베타-(엔-3차-부틸카바모일)-3-온 스테로이드 화합물의제조방법
CN100428897C (zh) * 2002-08-16 2008-10-29 浙江寿峰堂生物工程有限公司 抗疲劳改善亚健康的保健食品及其制备方法
ES2206065B1 (es) * 2002-10-31 2005-08-16 Ragactives, S.L. Procedimiento para la obtencion de la forma polimorfica i de finasterida.
WO2004083230A1 (en) * 2003-03-19 2004-09-30 Hetero Drugs Limited Novel crystalline forms of finasteride
DE602004016170D1 (de) * 2003-07-03 2008-10-09 Cipla Ltd Verfahren zur herstellung von finasterid form i
US20050136015A1 (en) * 2003-12-17 2005-06-23 McKie Derrick B. Topical use of halosalicylic acid derivatives
US20070167477A1 (en) * 2006-01-13 2007-07-19 Mandava Venkata Naga Brahmeswa Processes to prepare finasteride polymorphs
US7531658B2 (en) * 2006-01-20 2009-05-12 Apotex Pharmachem Inc. Process for the preparation of 17-N-substituted-carbamoyl-4-aza-androst-1-en-3-ones
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
WO2007089267A1 (en) 2006-02-03 2007-08-09 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US20090076058A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched finasteride
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2723398C (en) * 2008-05-05 2017-07-04 Abbott Gmbh & Co. Kg Method for evaluating the solubility of a crystalline substance in a polymer
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
DE3888378T2 (de) * 1987-04-03 1994-09-29 Merck & Co Inc Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5084574A (en) * 1988-04-18 1992-01-28 Merck & Co., Inc. Dehydrogenation process
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US5021575A (en) 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
DE69112917T2 (de) * 1990-06-15 1996-05-15 Merck & Co Inc Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
EP0462662A3 (en) * 1990-06-20 1992-08-19 Merck & Co. Inc. 17beta-n-monosubstituted adamantyl/norbornanyl carbamoyl-4-aza-5alpha-androst-1-en-3-ones and androstan-3-ones
US5120847A (en) † 1990-08-27 1992-06-09 Merck & Co., Inc. Process for iodinating or brominating the α-methylenic carbon of a secondary amide
US5091534A (en) 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
CA2050824A1 (en) * 1990-09-24 1992-03-25 John M. Williams Process for making 3-oxo-4-aza-androst-1-ene 17-.beta.-ketones
US5061801A (en) * 1990-09-24 1991-10-29 Merck & Co., Inc. Intermediate for making 3-oxo-4-aza-androst-1-ene 17β-ketones
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes

Also Published As

Publication number Publication date
DE69323754D1 (de) 1999-04-08
NO951986L (no) 1995-05-19
WO1994011387A2 (en) 1994-05-26
LV12460B (en) 2000-09-20
EP0599376A3 (en) 1994-09-28
FI20010290L (fi) 2001-02-15
JP2742409B2 (ja) 1998-04-22
JPH06199889A (ja) 1994-07-19
ATE177112T1 (de) 1999-03-15
ES2052476T3 (es) 1998-06-16
EP0599376B1 (en) 1998-04-08
SK286488B6 (sk) 2008-11-06
CA2103107C (en) 2010-09-28
DE69323754T2 (de) 1999-10-07
HU210535A9 (en) 1995-04-28
HRP931410B1 (en) 2000-06-30
EP0655458A2 (en) 1995-05-31
DE599376T1 (de) 1994-12-08
DE69317856T2 (de) 1998-11-05
RO115165B1 (ro) 1999-11-30
HRP20000295B1 (en) 2002-08-31
EP0823436A3 (en) 1998-11-25
HU9303275D0 (en) 1994-03-28
HUT66973A (en) 1995-01-30
RU2120445C1 (ru) 1998-10-20
DK0599376T4 (da) 2008-07-28
IL107574A (en) 2000-07-16
TW257766B (es) 1995-09-21
LV12460A (lv) 2000-04-20
NO990468D0 (no) 1999-02-01
AU658774B2 (en) 1995-04-27
IS4286A (is) 1994-05-20
CZ301191B6 (cs) 2009-12-02
BG64464B1 (bg) 2005-03-31
ES2052476T1 (es) 1994-07-16
FI952422A0 (fi) 1995-05-18
FI20010289L (fi) 2001-02-15
DK0655458T3 (da) 1999-09-27
HRP20000295A2 (en) 2000-08-31
CN1090583A (zh) 1994-08-10
EP0599376A2 (en) 1994-06-01
NO307888B3 (no) 2000-06-13
CZ126895A3 (en) 1995-12-13
BG103170A (en) 1999-09-30
SK281765B6 (sk) 2001-07-10
MY110411A (en) 1998-05-30
NO992580L (no) 1995-05-19
US5886184A (en) 1999-03-23
NO951986D0 (no) 1995-05-19
US5468860A (en) 1995-11-21
HRP931410A2 (en) 1996-06-30
BG99637A (bg) 1996-04-30
NO307888B1 (no) 2000-06-13
GR950300043T1 (en) 1995-07-31
NO307609B1 (no) 2000-05-02
ATE164850T1 (de) 1998-04-15
EP0823436A2 (en) 1998-02-11
DE69317856D1 (de) 1998-05-14
IS4094A (is) 1994-05-20
DZ1733A1 (fr) 2002-02-17
CA2103107A1 (en) 1994-05-20
MY110410A (en) 1998-05-30
AU5078793A (en) 1994-06-16
RO115164B1 (ro) 1999-11-30
GR3029554T3 (en) 1999-06-30
UA41341C2 (uk) 2001-09-17
LV12212B (en) 1999-03-20
JPH09235294A (ja) 1997-09-09
FI107450B (fi) 2001-08-15
US5652365A (en) 1997-07-29
JPH07110875B2 (ja) 1995-11-29
PH31120A (en) 1998-02-23
IL107574A0 (en) 1994-02-27
GR940300045T1 (en) 1994-07-29
IS1692B (is) 1998-04-20
WO1994011387A3 (en) 1994-09-29
CN1058018C (zh) 2000-11-01
FI114215B (fi) 2004-09-15
EP0655458A3 (en) 1996-07-10
DE655458T1 (de) 1995-11-30
GR3026577T3 (en) 1998-07-31
HU216195B (hu) 1999-05-28
SK65995A3 (en) 1995-10-11
ES2052476T5 (es) 2008-11-01
CY2135B1 (en) 2002-05-21
NO305912B1 (no) 1999-08-16
BG62362B1 (bg) 1999-09-30
NO992580D0 (no) 1999-05-28
FI952422L (fi) 1995-05-18
EP0655458B1 (en) 1999-03-03
SI9300603A (en) 1994-06-30
SI9300603B (sl) 2004-06-30
MX9307222A (es) 1994-07-29
RU95112521A (ru) 1997-02-10
LV12212A (lv) 1999-01-20
HK1008338A1 (en) 1999-05-07
IS1671B (is) 1997-12-19
EP0599376B2 (en) 2008-04-16
FI114800B (fi) 2004-12-31
FI116941B (fi) 2006-04-13
NO990468L (no) 1995-05-19
ES2072848T1 (es) 1995-08-01
CZ287842B6 (en) 2001-02-14
FI20040559A7 (fi) 2004-04-21
CZ301160B6 (cs) 2009-11-18

Similar Documents

Publication Publication Date Title
ES2072848T1 (es) Nuevo procedimiento de preparacion de finasterida.
PT1173402E (pt) Processo para a producao de acidos organicos e seus esteres
ES457932A1 (es) Un procedimiento para la preparacion de nuevos compuestos antiparasitarios c-076, obtenidos en un caldo de fermenta- cion.
KR890003775A (ko) 결정성 세파드록실 모노하이드레이트의 제조방법
ES2067580T3 (es) N-acetilneuraminato de sodio.trihidrato y metodo para su preparacion.
JPS52114092A (en) Preparation of l-arginine by fermentation process
JPS51149287A (en) Process for preparing 5-fluorouracil
JPS51113896A (en) Process for preparing adenosine phosphoric acid derivatives
JPS53126262A (en) Molecular beam epitaxial growth apparatus
JPS5283429A (en) Preparation of aromatic unsaturated carboxylic acid amide derivatives
US2951859A (en) Purifying and stabilizing acids and amines
KR850001729A (ko) L 또는 (s)-3-(3,4- 디히드록시페닐)-2-메틸알라닌에스테르의 결정성 염의 제조방법
CO5011092A1 (es) Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente
JPS539715A (en) Crystallization of dl-acetylmethionine
ES392575A1 (es) Un proceso de aislamiento de alfa-6 deoxitetraciclinas de gran pureza.
JPS5246017A (en) Process for preparation of farnesyl acetates
JPS51119398A (en) A method for purifying and concentrating caustic soda and hydrochloric acid using a liquid phase thermosyphon process
JPS5239671A (en) Process for preparing indole-3-thioether compounds
AR005903A1 (es) Un proceso para la preparacion de clorhidrato en n(g)-monometil-l-arginina
JPS51138602A (en) Process for preparing alpha-hydrazino carboxylic acids
MX2960E (es) Metodo de obtencion de glutamato de 5 - hidroxi - triptofano
JPS5215547A (en) Process for preparing dopes of aromatic polyamides
JPS51143645A (en) Process for preparation of 3,3-dimethyl- 2-(2,2-dihalo)cyclopropanecar boxylic acid ester
JPS5228497A (en) Method for the formation of silver nitrate
JPS5728011A (en) Preparation of amine using selenophenol

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 655458

Country of ref document: ES